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Carlos G. Reverte, Michael D. Ahearn, and Laura E. Hake1
Biology Department, Boston College, Chestnut Hill, Massachusetts 02467
Cytoplasmic poly(A) elongation is widely utilized during the early development of many organisms as a mechanism for
translational activation. Targeting of mRNAs for this mechanism requires the presence of a U-rich element, the cytoplasmic
polyadenylation element (CPE), and its binding protein, CPEB. Blocking cytoplasmic polyadenylation by interfering with
the CPE or CPEB prevents the translational activation of mRNAs that are crucial for oocyte maturation. The CPE sequence
and CPEB are also important for translational repression of mRNAs stored in the Xenopus oocyte during oogenesis. To
nderstand the contribution of protein metabolism to these two roles for CPEB, we have examined the mechanisms
nfluencing the expression of CPEB during oogenesis and oocyte maturation. Through a comparison of CPEB mRNA levels,
rotein synthesis, and accumulation, we find that CPEB is synthesized during oogenesis and stockpiled in the oocyte.
inimal synthesis of CPEB, <3.6%, occurs during oocyte maturation. In late oocyte maturation, 75% of CPEB is degraded
oincident with germinal vesicle breakdown. Using proteasome and ubiquitination inhibitors, we demonstrate that CPEB
egradation occurs via the proteasome pathway, most likely through ubiquitin-conjugated intermediates. In addition, we
emonstrate that degradation requires a 14 amino acid PEST domain. © 2001 Academic Press
Key Words: cytoplasmic polyadenylation; RNA binding protein; early development; oocyte maturation; PEST domain.INTRODUCTION
Early development in many invertebrate and vertebrate
systems relies on the precise translational regulation of
maternally inherited mRNAs (Wickens et al., 2000; Hake
and Richter, 1997; Richter, 1999). These mRNAs are syn-
thesized during oogenesis and stored in the oocyte cyto-
plasm, remaining in a repressed state until translation
during the completion of meiosis (oocyte maturation) or
during early embryogenesis. One prominent mechanism for
translational activation of maternal mRNAs is cytoplasmic
polyadenylation. The phenomenon of cytoplasmic polyad-
enylation was first discovered in sea urchins (Wilt, 1973;
Slater et al., 1973). Further analysis of cytoplasmically
polyadenylated mRNA in the surf clam, Spisula solidis-
sima, demonstrated that regulated adenylation of specific
maternal mRNAs correlated with changes in translation
(Rosenthal et al., 1983). Subsequent studies in organisms as
diverse as frogs, mice, and flies have confirmed that the
1 To whom correspondence should be addressed at Biology De-
partment, Higgins Hall, Boston College, Chestnut Hill, MA 02467.
Fax: (617) 552-2011. E-mail: hakel@bc.edu.
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All rights of reproduction in any form reserved.acquisition of a long poly(A) tail on the 39 end of the mRNA
correlates with translational activation, whereas the short-
ening of the poly(A) tail correlates with translational repres-
sion (Richter, 1999). Many of the details of cytoplasmic
polyadenylation have been elucidated in maturing Xenopus
and mouse oocytes (McGrew et al., 1989; Fox et al., 1989;
Vassalli et al., 1989; Fox et al., 1992; Huarte et al., 1992;
Hake and Richter, 1994; Verotti et al., 1996; Stutz et al.,
1998; Gillian-Daniel et al., 1998; Mendez et al., 2000a,b).
Essentially, mRNAs that are regulated via cytoplasmic
polyadenylation require the presence of two sequence ele-
ments within their 39UTRs: the nuclear polyadenylation
hexanucleotide, AAUAAA, and a unique U-rich sequence,
the cytoplasmic polyadenylation element (CPE). The CPE is
specifically bound by the CPE binding protein, CPEB,
which contains a novel RNA binding domain consisting of
two RNA recognition motifs followed by a zinc-finger
(Hake et al., 1998). CPEB binding to the CPE is necessary for
cytoplasmic polyadenylation (Hake and Richter, 1994;
Stebbins-Boaz et al., 1996).
Recent analyses have demonstrated that translational
repression is functionally linked to translational activation
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448 Reverte, Ahearn, and Hakein both Xenopus (de Moor and Richter, 1999) and mouse
(Tay et al., 2000). Reporter mRNAs containing a CPE
upstream of a nuclear polyadenylation hexanucleotide are
translationally masked when injected into immature oo-
cytes in comparison to the same mRNAs lacking CPEs.
During oocyte maturation, only the CPE-containing
mRNAs are cytoplasmically polyadenylated and transla-
tionally activated (de Moor and Richter, 1999). In immature
oocytes, CPEB may mediate translational repression
through an interaction with Maskin, which is an eIF4E
binding protein that may interfere with recruitment of
eIF4G to the translation initiation complex (Stebbins-Boaz
et al., 1999). The CPE and CPEB thus have a dual function
in early Xenopus development: the masking of maternal
mRNAs from the translational apparatus (de Moor and
Richter, 1999; Stebbins-Boaz et al., 1999) and the cytoplas-
mic polyadenylation of these messages (Hake and Richter,
1994; Stebbins-Boaz et al., 1996).
The dual function of CPEB may be regulated by alter-
tions in its phosphorylation state. During oocyte matura-
ion, CPEB is sequentially phosphorylated on multiple
esidues (Paris et al., 1991; Mendez et al., 2000a). Phosphor-
lation on serine 174 by Eg2 kinase recruits cleavage and
olyadenylation specificity factor (CPSF) into an active
ytoplasmic polyadenylation complex (Mendez et al.,
000b). In vivo, Eg2 phosphorylation of CPEB within 2 h of
nduction of maturation activates CPEB’s ability to mediate
-mos mRNA cytoplasmic polyadenylation (Mendez et al.,
000a). Later in maturation (;4 h after induction), CPEB is
hosphorylated in a cdc2-dependent manner and ;75% is
egraded, coincident with the onset of germinal vesicle
reakdown (GVBD; de Moor and Richter, 1997), the first
isible indication that meiosis has reinitiated. These late
hosphorylation events correlate with the switch from the
asked to the translationally activated state of additional
mportant maternal RNAs such as cyclin B1 and histone B4
de Moor and Richter, 1997). The pool of CPEB that remains
s also phosphorylated and is present in mature oocytes and
ggs, where cytoplasmic polyadenylation is robust (Hake
nd Richter, 1994). It is currently unknown, however,
hether there is a functional link between CPEB degrada-
ion and release from translational repression of a CPE
ontaining mRNA in the maturing oocyte. In addition, the
unctional differences which allow one population of CPEB
o be targeted for degradation and yet another to be pro-
ected from degradation are unknown.
We are interested in how the fate of an individual CPEB
olecule is determined within the context of its transition
rom a translational repressor to a translational activator. A
ecessary component of this line of inquiry is knowledge of
he principal factors that regulate the quantity of CPEB
uring oogenesis and oocyte maturation. In the current
tudy, we have found that CPEB mRNA levels remain
onstant during early oogenesis. After a 20% increase in
verall CPEB protein levels during late oogenesis, no sig-
ificant synthesis of CPEB occurs during oocyte matura-
ion. CPEB protein thus appears to be stockpiled and stable p
Copyright © 2001 by Academic Press. All rightntil GVBD, when 75% is degraded. We demonstrate that
egradation of CPEB requires the proteasome and a 14
mino acid PEST domain that is conserved in vertebrate
nd clam CPEB. Targeting to the proteasome may also
nvolve CPEB ubiquitination.
MATERIALS AND METHODS
Plasmid Constructs
The construction of HA-CPEB was identical to that of Myc-
CPEB (Hake and Richter, 1994), except that the 59 primer sequence
for PCR was 59 GTGCTCTAGATGGAATATCCATATGATGTGC-
CAGATTATGCTGGACTGATGGCCTTCCCACTGAAAGAT 39.
DPESTS and DPESTL were constructed by using the polymerase
chain reaction with oligonucleotides flanking the regions to be
deleted (codons 182–196 or 182–209, respectively), but designed so
that amplification proceeded away from that region and around the
entire plasmid. The 39 antisense primer was identical for genera-
tion of both deletion mutants, began on the 59 side of the nucleo-
tides encoding codon 182, and was 59 TCTAGAATCCAAAATA-
GAGCG 39. For generation of DPESTS, the 59 sense primer began 39
of the nucleotides encoding codon 196 and was 59 TCTGACCAC-
CTTTCAGACCTA 39. The DPESTL sense 59 primer began 39 of the
nucleotides encoding codon 209 and was 59 TCTCCTCCGCTG-
CATTTC 39. Silent mutations were created at codons 181 (CGC
224 AGA) and 197 (TCA 224 TCT) to generate a unique BglII site
that was used for ligation of the resultant PCR products and to
screen for the deletion mutants. Double-stranded sequencing of the
coding region of both mutants confirmed that the appropriate
deletions were obtained and that no additional mutations were
introduced.
Oocyte Isolation and Culture
For maturation experiments, Xenopus laevis females were
primed with 50 IU pregnant mare serum gonadotropin 3–6 days
before removal of ovarian lobes. These were digested with collage-
nase and dispase to release the oocytes (Kuge and Richter, 1995),
which were incubated in 13 Barth’s for at least 3 h prior to use.
Oocytes corresponding to Dumont Stages I–VI (Dumont, 1972)
were grouped based on size, rinsed with 13 XB (Hake and Richter,
1994), and stored at 280°C until use.
RNA Transcription and Injections
pHA-CPEB and deletion mutants were linearized with XhoI, and
in vitro transcription was performed with the Mmessage Mma-
chine kit from Ambion (Austin, TX), following the manufacturer’s
procedure. RNA was extracted with phenol/chloroform and then
ethanol precipitated twice. Sets of oocytes were injected at the
equatorial band with 50 nl of a 2 ng/ml solution of HA-tagged CPEB
RNA for a final concentration of ;100 ng per oocyte. As a control
or injection-mediated activation, additional oocytes were injected
ith buffer alone. Injected oocytes were incubated in 13 Barth’s
aline supplemented with streptomycin for a minimum of 15 h to
llow protein synthesis, before induction of maturation with
rogesterone.
s of reproduction in any form reserved.
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449PEST Domain and 26S Proteasome CPEB DegradationNorthern Blot Analysis
RNA was isolated from oocytes at the indicated stages of
development and analyzed by Northern blotting as described (Hake
et al., 1990). The PstI fragment of p12.5 (xCPEB; Hake and Richter,
1994) was random-prime labeled with a32P-dCTP using the Deca-
prime kit (Ambion) following the manufacturer’s instructions.
Membranes were hybridized and washed following the procedure of
Church and Gilbert (1984) and visualized by autoradiography.
35S-Methionine Incorporation Assays
Stage VI oocytes were placed in a 10 3 35 mm Petri dish and
induced to mature with 10 mg/ml progesterone. Immediately
ollowing the addition of the hormone, 30 oocytes were injected
ith 46 nl of 1104 Ci/mmol 35S-methionine (New England
uclear). After 1 h, 25 of the 30 maturing oocytes were frozen on
ry ice. Directly following freezing of the first set, a second set of
0 oocytes was removed from the pool of maturing oocytes,
njected with 35S-methionine, incubated for 1 h, and frozen. This
pattern was repeated every hour until 50% of the remaining
oocytes had undergone maturation, which was scored by the
presence of a white spot in the animal pole, indicative of germinal
vesicle (nuclear) breakdown (GVBD) and the resumption of meiosis
I. At this point a final hour of injections was completed. The final
percentage of maturation varied from 75–90%. All oocytes were
stored at 280°C.
Extracts of the frozen oocytes were prepared by homogenization
in 13 XB with protease inhibitors followed by centrifugation (Hake
and Richter, 1994). To compensate for variability in the amount of
35S-methionine injected and retained within the oocyte, extracts
containing equivalent amounts of radioactivity from each time
point were used for immunoprecipitation. CPEB was immunopre-
cipitated from the cleared supernatant of 25 oocytes by addition of
10 ml protein A sepharose beads prebound with 2 ml of anti-CPEB
polyclonal antibody (Hake and Richter, 1994). Two additional
rounds of immunoprecipitation with anti-CPEB–protein A sepha-
rose beads ensured capture of over 95% of the radiolabeled CPEB.
The beads from all three immunoprecipitations were combined,
washed with 13 NET buffer (Sambrook et al., 1989) 3 times, boiled
with sample loading buffer, and analyzed by SDS–PAGE and
autoradiography. Gel slices containing radioactive CPEB were
excised, solubolized in Solvable (Packard Bioscience) overnight,
and counted in Econosafe scintillation fluid (Research Products
International).
Calculations of CPEB synthesis rates included the following
variables: 0.4 pm of 1104 Ci/mmol 35S-methionine were injected
into oocytes containing an endogenous pool of 27 pm of
methionine/oocyte (O’Connor, 1994). Values were corrected for
quenching in the solvable/scintillation fluid, background counts,
and the molar ratio of CPEB to methionine (CPEB contains 13
methionines). The necessary conversions from counts-per-minute
to milliCuries were also performed.
Injection of Proteasome and Ubiquitination
Inhibitors
Oocyte maturation was induced by addition of progesterone.
Groups of non-GVBD oocytes were selected from batches of
oocytes where 50% had achieved GVBD (GVBD50) and injected
ith 50 nl of buffer, or a solution containing different inhibitors or
combination of them, as indicated, at the following concentra-
Copyright © 2001 by Academic Press. All rightions: 400 mM methylated ubiquitin, 20 mM ubiquitin aldehyde, 1
M carbobenzoxyl-leucinyl-leucinyl-leucinal (MG132), or 1 mM
64. All of the injected solutions contained 10% DMSO. The
njected oocytes were incubated further until 100% GVBD. For
ach time point, five oocytes were collected in a microcentrifuge
ube, washed with 13 XB, frozen on dry ice after removing all
xcess buffer, and then stored at 280°C.
Immunoblotting
Oocyte extracts from each time point or treatment were pre-
pared as described (Hake and Richter, 1994). Two and one-half
oocyte equivalents of protein extract were boiled with SDS sample
loading buffer and electrophoresed on a 10% SDS–polyacrylamide
gel. Immunoblotting analysis was performed as described (Hake
and Richter, 1994). Primary antibody dilutions were 1:2000 for
rabbit polyclonal anti-CPEB; 1:1000 for mouse monoclonal
anti-HA (Babco); and 1:5000 for rabbit polyclonal anti-Xp54 heli-
case (Ladomery et al., 1997). The secondary antibodies were goat
nti-rabbit IgG–HRP (1:20,000 dilution; Vector Laboratories), and
oat anti-mouse IgG–HRP (1:10,000 dilution; Santa Cruz Biotech-
ology). HRP-linked secondary antibodies were detected by en-
anced chemiluminescence using the Renaissance Kit (NEN Life
cience Products). Quantification of immunoblots was performed
y obtaining a range of film exposures for each antibody set, and
nalyzing identical samples on several different immunoblots. All
xposures were then scanned in a Molecular Dynamics densito-
eter. Values for each band that were within the linear range of the
lm were averaged and adjusted relative to the amount of the
ontrol, Xp54 immunoblot (whose band density was similarly
etermined).
Assay for Proteasomal Activity
The peptidase activity of the proteasome in extracts from either
mature or immature oocytes was measured using slight modifica-
tions of the procedures of Glas et al. (1998) by adding 2 ml extract
and 1 ml of a 10 mM stock of the fluorogenic peptide, N-succinyl-
leu-leu-val-tyrosine-7-amido-methylcoumarine (Suc-LLVY-MCA;
Sigma, St Louis, MI) to 97 ml buffer I (50 mM Tris pH 7.4, 2 mM
DTT, 5 mM MgCl2, 2 mM ATP). The mixture was incubated at
room temperature with time points removed at 15, 30, 45, and 60
min. The reaction was stopped by addition of 3 ml 1% SDS.
Peptidase activity results in release of the fluorescent MCA moi-
ety, which was monitored by excitation at 350 nm and fluorescent
emission at 440 nm (Shimadzu RF5000). To study the influence of
MG132 on Suc-LLVY-MCA hydrolytic activity in the extract, 1 ml
f a 4 mM stock solution (in 40% DMSO) of MG132 was preincu-
ated with the extract at room temperature for 20 min before
ddition of the fluorogenic peptide.
RESULTS
CPEB Is Synthesized during Oogenesis and
Stockpiled in the Oocyte
As a basis for our investigations into the role of CPEB in
translational repression and cytoplasmic polyadenylation,
we examined the mechanisms regulating CPEB protein
levels during oogenesis and oocyte maturation. First, CPEB
mRNA and protein accumulation during oogenesis and
s of reproduction in any form reserved.
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450 Reverte, Ahearn, and Hakeoocyte maturation were compared to determine whether
significant alterations in mRNA levels could account for
the 75% decrease in CPEB protein levels observed during
oocyte maturation (Hake and Richter, 1994; de Moor and
Richter, 1997). On a per oocyte basis, CPEB mRNA accu-
mulates during early oogenesis until Stage III, remains
constant through Stage V oocytes, decreases slightly in
Stage VI oocytes, and then remains relatively constant
throughout oocyte maturation (Fig. 1A). CPEB mRNA lev-
els were normalized by comparison to those of cyclin B1
FIG. 1. Developmental distribution of CPEB mRNA and protein
during oogenesis and oocyte maturation. (A) Total RNA from one
oocyte at each of the indicated stages was analyzed by Northern
blotting and hybridization with either a 32P-labeled CPEB cDNA
robe or a similarly labeled cyclin B1 cDNA probe (indicated to left
f panels). The reverse image of a portion of the EtBr stained gel
howing the 28s ribosomal RNA is included in panel 3. “Stage of
ogenesis” represents the 6 Dumont oocyte stages (Dumont, 1972).
Hours in progesterone” indicates oocytes that were collected 2
nd 3.5 h after addition of progesterone to Stage VI oocytes to
nduce maturation. M indicates RNA isolated from a mature
ocyte, scored by the appearance of a white spot (GVBD). The
mount of CPEB mRNA relative to cyclin B1 (loading control) is
ndicated by CPEB/B1. (B) Soluble protein from one oocyte at each
f the indicated stages was analyzed by SDS–PAGE and immuno-
lotting with anti-CPEB polyclonal antiserum or anti-Xp54 poly-
lonal antiserum and detected by enhanced chemiluminescence.
amples are identical to those analyzed in part A above. The
umbers in the C/54 row indicate the level of CPEB expressed in
hat stage relative to the level of Xp54.mRNA (panel 2) and ribosomal RNA (panel 3). Kobayashi et
Copyright © 2001 by Academic Press. All rightl. (1991) demonstrated, using RNAse protection, that cy-
lin B1 mRNA is present in equivalent amounts per oocyte
hroughout oogenesis. Normalized values for CPEB mRNA
evels were obtained by dividing the CPEB mRNA band
ensity by the cyclin B1 mRNA band density (values
ndicated by CPEB/B1). CPEB mRNA levels during oocyte
aturation were compared to those for rRNA, as rRNA
evels remain constant throughout oocyte maturation
Busby and Reeder, 1982).
The amount of CPEB protein per oocyte increases be-
ween Stages I and II of oogenesis (compare lanes 1 and 2,
ig. 1B) and remains relatively constant until the transition
rom Stage V to Stage VI oocytes (lanes 5 and 6), where there
s an approximately 20% increase in amount. During early
ocyte maturation, CPEB protein levels are stable and then
ecline drastically during late maturation, decreasing to
5% of the level found earlier, as previously observed (Hake
nd Richter, 1994; de Moor and Richter, 1997, 1999).
lterations in the levels of CPEB protein are apparent when
ormalized against the amount of the Xenopus helicase,
p54. Ladomery et al. (1997) demonstrated that Xp54 is
aintained at a constant level per oocyte throughout oo-
enesis and oocyte maturation. The ratio of CPEB band
ensity divided by Xp54 band density is indicated (CPEB/
p54, Fig. 1B). The doublet observed in lane 4 for Xp54 was
ot reproducible.
In summary, CPEB protein appears to be stockpiled early
uring oogenesis, with either increased stabilization or
ncreased protein synthetic activity contributing to an
ncrease in amount between Stages V and VI of oogenesis.
arallel expression of CPEB mRNA and protein until Stage
II suggests that CPEB mRNA is readily available for trans-
ation during this time. The decrease in CPEB protein level
n late oocyte maturation (M, lane 9, Fig. 1B) does not
orrelate with the stable level of CPEB mRNA (M, lane 9,
ig. 1A), indicating that the decrease in CPEB protein is not
ue to an increase in CPEB mRNA instability.
CPEB Synthesis Is Minimal during Oocyte
Maturation
Although the previous analyses indicate that CPEB pro-
tein accumulates and that overall levels remain relatively
constant until GVBD, they do not reveal the dynamics of
protein synthesis and degradation that could contribute to
alterations in the CPEB pool. More specifically, it is unclear
whether the CPEB present in mature oocytes, which is
necessary for cytoplasmic polyadenylation, arises from new
protein synthesis during oocyte maturation, or by protec-
tion from the degradation that removes over 75% of CPEB
from the oocyte.
To examine the potential contribution of new CPEB
synthesis to the CPEB pool during oocyte maturation, we
analyzed the rates of CPEB synthesis in Stage VI oocytes
and at 1-h intervals during oocyte maturation (Fig. 2). To
analyze CPEB synthesis during oocyte maturation, oocytes
were induced to mature with progesterone and then in-
s of reproduction in any form reserved.
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451PEST Domain and 26S Proteasome CPEB Degradationjected with 35S-methionine at 1-h intervals. Time points
were collected from each set of oocytes 1 h after each batch
of injections, thus generating samples that represented 1-h
windows of labeling. Labeled oocytes were harvested and
analyzed for incorporation of 35S-methionine into newly
synthesized CPEB by immunoprecipitation with anti-CPEB
antibody, PAGE separation of proteins, and autoradiogra-
phy. Figure 2 is a representative autoradiogram of samples
that were subsequently used for calculation of synthesis
rates (see Materials and Methods). As seen in Fig. 2, the
overall rate of new CPEB synthesis and accumulation
increases between 1 and 3 h after induction of maturation
(compare lanes 2 and 4) and then remains relatively con-
stant. Our calculations indicate that these rates range from
4.7 pg/h in resting, Stage VI, oocytes, to a peak of 8 pg/h
during the third hour of maturation (compare lanes 1 and 4).
Notably, CPEB accumulation continues at a steady rate,
comparable to that during hour 3, even after 50% of the
oocytes have undergone GVBD (GVBD50; compare lane 7
with lane 4). During a typical 6-h maturation period, a total
of 36 pg of newly synthesized CPEB accumulates, contrib-
uting 3.6% to the 1 ng of CPEB present in mature oocytes
(Hake and Richer, 1994).
CPEB Is Degraded by the Proteasome Pathway
CPEB levels decrease by over 75% at the time of GVBD
(de Moor and Richter, 1997). The principle mechanism for
specific degradation of cytoplasmic proteins is the
ubiquitin-proteasome pathway (Ciechanover, 1994; Hoch-
strasser, 1996; Varshavsky, 1997; Hershko and Ciech-
anover, 1998). To examine the role of the proteasome in
FIG. 2. CPEB protein synthesis during oocyte maturation. 35S-
methionine was injected into groups of oocytes at 1-h intervals
during oocyte maturation and CPEB was immunoprecipitated from
each group 1 h after injection and analyzed by SDS–PAGE and
autoradiography. The time when 50% of the oocytes had under-
gone GVBD is indicated by GVBD50. “Pg/hr” indicates the rate of
protein synthesis in picograms per hour during maturation. “Fold
increase” indicates the change in accumulation of newly synthe-
sized CPEB protein relative to that occurring in stage VI oocytes
(lane 1).CPEB degradation, we investigated the influence of protea-
Copyright © 2001 by Academic Press. All rightome pathway inhibitors on the metabolism of endogenous
PEB in vivo. CPEB is degraded coincident with GVBD,
hich occurs ;4 h into the ;6-h maturation process. To
void perturbing early events in maturation that may re-
uire proteasome activity (Sawada et al., 1997), we at-
empted to block CPEB degradation by injecting inhibitors
nto oocytes in which maturation had been initiated but
ad not yet advanced to GVBD. We found that non-GVBD
ocytes taken from a batch of maturing oocytes where 50%
ad achieved GVBD (GVBD50) were suitable for these stud-
ies.
MG132 is a membrane-permeant peptide aldehyde
widely used to block the chymotryptic activity of the
proteasome (reviewed by Lee and Goldberg, 1998). Because
its effects last for several hours without obvious toxicity to
the cells (Rock et al., 1994), we used this inhibitor for our in
vivo assays. We analyzed the influence of MG132 on CPEB
degradation during progesterone-induced maturation by in-
jecting nonwhite spot oocytes at GVBD50 with either
MG132 or buffer with 10% DMSO (Fig. 3A). Time points
were taken immediately after addition of progesterone
(immature; Im), at GVBD50 (G50), and 10 and 120 min after
00% GVBD (M10 and M120). The pattern of CPEB expres-
ion in control buffer-injected immature oocytes (lane 1),
nd the decrease in CPEB level apparent when the oocytes
ere fully mature (M120; compare lanes 2 and 4), is identical
to that observed during maturation of nonperturbed oocytes
(data not shown; de Moor and Richter, 1997). The injection
of MG132 into oocytes at GVBD50 successfully blocked the
degradation of CPEB that occurs as oocytes progress
through GVBD (MG132/M120, lane 5), whereas injection of
0% DMSO alone did not (compare lanes 4 and 5). The rate
nd percentage of GVBD in the MG132-injected oocytes
ere similar to that observed for buffer injected oocytes
Fig. 3B). The calpain inhibitor E-64 did not affect CPEB
egradation or proteasomal activity (data not shown).
As a control for proteasomal activity in all of these
amples, quick cytoplasmic extracts were prepared from
mmature and mature oocytes and tested for their ability to
egrade the fluorogenic peptide, Suc-Leu-Leu-Val-MCA, in
spectrofluorometric assay (Fig. 3C). The proteasome was
ctive in extracts from both immature and mature oocytes
ith nearly identical activities at 79.4 6 16.1 and 82.6 6
3.2 Functional Units/(milligrams of extract protein 3
inutes), respectively. Addition of MG132 to extracts ef-
ectively inhibited the proteasome and reduced the protea-
ome activity in immature and mature oocyte extracts to
0.8 6 2.9 and 8.05 6 2.4 FU/(mg 3 minutes), respectively.
Deletion of the PEST Domain Prevents
Degradation of CPEB
Regions rich in proline, glutamate, serine, and tyrosine
(PEST sequences) target proteins for rapid degradation
(Rechsteiner and Rogers, 1996). Our comparison of CPEB
homologs from frog, mouse, and clam (Walker et al., 1999)
revealed a highly conserved 15 amino acid domain that
s of reproduction in any form reserved.
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452 Reverte, Ahearn, and Hakescored 19.18 with the PESTFind algorithm (lightly shaded
box, Fig. 4A; Rogers et al., 1986; http://www.icnet.uk/cgi-
FIG. 3. Degradation of endogenous CPEB during maturation is
locked by the proteasome inhibitor MG132. (A) Immature oocytes
Im) were induced to mature by addition of progesterone. At
VBD50 (G50) 50 nl of buffer plus 10% DMSO alone or with 1 mM
MG132 were injected into non-GVBD oocytes and a sample was
immediately taken (lane 2). The remaining oocytes were incubated
until 10 or 120 min after 100% GVBD (M10 and M120, lanes 3–5).
rude protein extracts were then analyzed by SDS–PAGE, immu-
oblotting with anti-CPEB antiserum and detection by enhanced
hemiluminescence. The open arrow indicates the position of
ndogenous CPEB (eCPEB) in immature oocytes. The filled arrow
ndicates the position of phosphorylated eCPEB. (B) The percentage
VBD and the amount of time to achieve GVBD for oocytes
njected with MG132 was virtually identical to that of buffer-
njected oocytes. Oocytes from frog 2 were 65% mature after 12 h
f observation, and this did not change after overnight (18 h)
ncubation. (C) Spectrofluorimetric proteasome activity assay. Ex-
racts from immature and mature oocytes were assayed for their
bility to degrade a fluorogenic peptide as monitored by spec-
rofluorimetry. Proteasomal activity in the extracts is expressed as
unctional units/milligrams of protein extract 3 minutes (FU/
g 3 min). The effect of MG132 on this activity was assessed by
ddition of 40 mM MG132 to the reaction (lanes indicated with
“MG132”). Control lanes (“Buffer”) received 1 ml of 40% DMSO
vehicle.in/runpest.pl). Further comparison of this region with
Copyright © 2001 by Academic Press. All rightPEB homologs from human and zebrafish revealed that
ignificant, high PEST homology extends for an additional
3 amino acids (Fig. 4A; entire shaded region). This ex-
ended PEST domain scores 17.75 with PESTFind, a value
igher than PEST sequences functionally proven to be
roteolytic signals in a number of short-lived proteins
reviewed in Rechsteiner and Rogers, 1996). The 28 amino
cid PEST domain is interrupted by a histidine and hence is
ipartite because positively charged amino acids are not
enerally found within PEST sequences. Outside of the
EST domain, the amino terminal halves of vertebrate and
lam CPEB are not highly conserved. In contrast, the
arboxy-terminal domains containing the RNA recognition
otifs and the zinc finger domain are highly conserved.
Based on the conserved nature of the PEST domain in the
PEB protein family and the high score that this region has
ith the PEST-find program, we tested the hypothesis that
his domain might be required for targeting CPEB for
egradation. A deletion mutant of HA-tagged CPEB was
onstructed that removed the extended PEST domain
DPESTLong, Fig. 4B). The metabolism of wild-type HA-
PEB and the DPESTL mutant during oocyte maturation
as assessed by in vivo translation of the wild-type and
utant mRNAs, followed by HA-immunoblotting (see Ma-
erials and Methods). The processing of wild-type HA-CPEB
uring progesterone-induced oocyte maturation was identi-
al to that observed for endogenous CPEB (compare Fig. 4C,
anes 1–4 with Fig. 3A). HA-CPEB is present in immature
ocytes. Ten minutes after the appearance of GVBD (M10),
the electrophoretic mobility of HA-CPEB is reduced; then
at 120 min after GVBD (M120), over 80% of the protein is
degraded. This degradation of HA-CPEB is also mediated by
the proteasome, as shown by the prevention of degradation
by injection of oocytes with MG132 (Fig. 4C, lane 4).
HA-CPEB containing a deletion of the PESTL domain
(DPESTL, Fig. 4B) is not degraded during oocyte maturation:
at M120, the level of DPESTL is similar to that present in
immature oocytes (Fig. 4C compare lane 10 with 8). In
addition, only half of the DPESTL shifts to a lower mobility
form (lanes 9 and 10), whereas all of the wild-type HA-CPEB
(Fig. 4C, lanes 2–4) and endogenous CPEB (Fig. 3, lanes 3–5)
migrate more slowly in SDS–PAGE.
To examine the possibility that there may be a smaller
region within the 28 amino acid PESTL domain that is the
signal for degradation, we deleted 14 amino acids of the
PEST domain conserved in vertebrate and clam CPEB
(DPESTS; Fig. 4B) and examined its metabolism during
oocyte maturation (Fig. 4C, lanes 5–7). Deletion of PESTS
also prevents CPEB degradation during oocyte maturation
(lanes 5–7). Although it appears from this immunoblot that
DPESTS is not stabilized to the same extent as DPESTL, this
appears to be an artifact of the variable levels of recombi-
nant protein expression in individual oocytes. Further anal-
ysis of multiple sets of oocytes expressing each of the three
recombinant proteins indicates that, whereas HA-CPEB is
always degraded, in comparison, DPESTS and DPESTL are
each 80–100% stabilized (data not shown). Thus, a se-
s of reproduction in any form reserved.
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Copyright © 2001 by Academic Press. All rightquence necessary for CPEB degradation is contained within
the 14 amino acids deleted from DPESTS.
Methylated Ubiquitin and Ubiquitin Aldehyde
Stabilize Several Larger Forms of CPEB in
Immature Oocytes
The majority of proteins degraded by the proteasome are
targeted to this multi-subunit protease through the attach-
ment of ubiquitin to lysine residues by isopeptide bonds.
Polyubiquitination can occur by the attachment of addi-
tional ubiquitin molecules to lysines in the host protein, to
lysines in the attached ubiquitins, or a combination of these
activities. These multiubiquitinated protein species are
excellent substrates for degradation by the proteasome.
Analysis of mono- and polyubiquitinated protein species is
difficult, however, because the ubiquitinated protein is
such a good substrate for the proteasome (reviewed by
Hershko and Ciechanover, 1998; Koegl et al., 1999). There
can also be significant isopeptidase activity that acts to
deubiquitinate proteins. Several modified forms of ubiq-
uitin can be used to interfere with the metabolism of
ubiquitinated proteins and thus help preserve ubiquitinated
protein intermediates. Methylated ubiquitin hinders poly-
ubiquitination of proteins because it can not serve as a
substrate for further ubiquitination (Hershko and Heller,
1985). However, methylated ubiquitin can be a substrate of
ubiquitin-protein lyases that normally recycle ubiquitin
from ubiquitin conjugates. Ubiquitin aldehyde efficiently
inhibits these lyases and other isopeptidases (Dang et al.,
1998), causing an increase in ubiquitin conjugates and a
significantly decreased rate of conjugate breakdown (Her-
shko and Rose, 1987; Shaeffer and Cohen, 1996). Thus, we
used a combination of both ubiquitin species to try to
perturb the degradation of CPEB and, at the same time,
enhance the retention of potentially ubiquitinated CPEB
intermediates.
We first analyzed the effect of methylated ubiquitin and
ubiquitin aldehyde on CPEB by injection of these deriva-
tives into immature oocytes, incubating the oocytes for 60
min, and then analyzing CPEB by immunoblotting (Fig.
5A). By the 60-min time point (lane 3), the accumulation of
a 74 kDa CPEB reactive band is evident, presumably due to
the retention of ubiquitinated CPEB in the immature oo-
cyte. Uninjected oocytes incubated in parallel did not
accumulate this species (as seen in Fig. 3, lane 1). The
modified form is larger, at 74 kDa, than the typical phos-
phorylated species observed in mature oocytes of 64 kDa
(Paris et al., 1991). To compare these two size variants of
PEB directly, the sample electrophoresed in Fig. 5A, lane
, was reelectrophoresed on a longer gel (Fig. 5B, lane 1) and
ompared with a time course of CPEB expression during
ormal maturation (Fig. 5B, lanes 2–4). The 74-kDa form of
PEB is clearly larger than the 64-kDa phosphorylated form
f CPEB present in mature oocytes (Fig. 5B, compare lane 1
ith lane 4 and refer to lighter exposure below).FIG. 4. Deletion of the PEST domain prevents CPEB degradation.
(A) Comparison of the PEST domain (shaded) and flanking amino
acids in vertebrate and clam CPEB. Light shading: PEST domain
conserved in clam. Dark shading: extended PEST domain conserved
in vertebrates. The initial PEST domain amino acid and accession
numbers are frog (Arg181, gb AAA80483.1) mouse (Arg178,
NP 031781.1), human (Arg104, dbj BAB14496.1), Z-fish 1 (Zor1,
Ser173, dbj BAA75637.1), Z-fish 2 (Zor2, Ser144, dbj BAA75638.1), and
clam p82 (Arg230, gb AF091712). Only amino acids that are identical
among the various proteins are shown. A plus sign (1) indicates the
osition of conservative amino acid differences in comparison with
enopus CPEB. Dashes indicate where gaps were introduced to aid in
lignment. Amino acids in bold are positively charged. (B) Schematic
iagram of wild-type HA-tagged CPEB and PEST deletion mutants.
aps indicate the position of the amino acids removed from wild-type
PEB to generate DPESTS and DPESTL. The RNA binding domain is
ndicated by R1 (RNA recognition motif 1), R2 (RNA recognition
otif 2), and ZF (zinc-finger domain). The asterisk indicates the
osition of the Eg2 phosphorylation site. (C) RNA encoding HA-
agged CPEB or the indicated deletion mutant was injected into
mmature oocytes, which were subsequently incubated overnight. In
he morning, immature oocytes (Im) were induced to mature with
rogesterone. For HA-CPEB, 50 nl of buffer plus 10% DMSO alone or
ith 1 mM MG132 were injected into non-GVBD oocytes at GVBD50
(G50). Oocytes were incubated until 10 or 120 min after 100% GVBD
(M10 and M120, lanes 2–4). For the deletion mutants, no injections of
DMSO or MG132 were performed, and samples were taken at the
indicated times after appearance of GVBD. Protein extracts from 2.5
oocytes for each sample were analyzed by SDS–PAGE, immunoblot-
ting with anti-CPEB antiserum, and chemiluminescence. The immu-Intriguingly, in sets of nonperturbed, synchronous, and
s of reproduction in any form reserved.
c
C
f
t
o
G
a
b
p
p
a
a
454 Reverte, Ahearn, and Hakerapidly maturing oocytes, CPEB caught just prior to degra-
dation, at GVBD50, has a heterogeneous size distribution
that is not observed in either immature or mature nonper-
turbed oocytes (compare Fig. 5B, lane 3, with Fig. 5A lane 1,
and Fig. 5B lane 4): There is a cluster of bands from 64–68
kDa and a larger band of 74 kDa (lane 3). The cluster of
CPEB reactive bands over 90 kDa does not appear reproduc-
ibly, even when the same sample is analyzed on subsequent
gels and is thus not considered to be CPEB. The shift
upward of the 62 kDa band to 64 kDa is most apparent in
the shorter exposure and upon comparison to the position
of Xp54 on the same immunoblot. We suspect that this
upward shift is due, at least in part, to hyperphosphoryla-
tion, which occurs during oocyte maturation (Paris et al.,
1991). Notably, the 74-kDa band (lane 3, Fig. 5B) has the
same mobility as the potentially ubiquitinated 74-kDa band
in immature oocytes treated with methylated ubiquitin and
ubiquitin aldehyde (lane 1). This observation suggests that
FIG. 5. Methylated ubiquitin and ubiquitin aldehyde stabilize uni
were injected with 50 nl of inhibitor cocktail containing 400 mM
control buffer containing 10% DMSO. Time points were taken
SDS–PAGE, immunoblotting with anti-CPEB antibody, and chemil
immunoblots were reprobed with anti-Xp54 antibody as a loadi
reelectrophoresed on a longer gel (lane 1) with the following addi
mature with progesterone. Time points were taken 2 h after induct
of maturation (M60). For lanes 5 and 6, methylated ubiquitin and u
nalyzed as in part A, above. A lighter exposure is presented in th
etween parts A and B, and to the right of the light exposure. (
roteasome is blocked by MG132. Oocytes were primed with
rogesterone. Time points were removed at GVBD50, M60, and a
nalyzed as above, except with anti-HA antibody. The positions
ppropriate immunoblots are indicated.the 74-kDa band in lane 3, which has arisen through the
Copyright © 2001 by Academic Press. All rightourse of normal CPEB metabolism, may be ubiquitinated
PEB.
In addition, recombinant HA-CPEB observed at GVBD50
and when the proteasome is blocked also has a very heter-
ogeneous size distribution (Fig. 5C, lanes 2 and 4). The
74-kDa band appears at GVBD50 and then, in mature oo-
cytes, the amount of HA-CPEB is greatly reduced, and only
the 64-kDa band is evident. Although not observed for the
endogenous protein example shown in Fig. 2A, this same
array of size variants has been observed for endogenous
CPEB at GVBD50 in other experiments (data not shown).
Further evidence that ubiquitination of CPEB is required
or targeting it for degradation was obtained by monitoring
he effects of methylated ubiquitin and ubiquitin aldehyde
n CPEB degradation during oocyte maturation. Non-
VBD oocytes at GVBD50 were injected with these modi-
fied forms of ubiquitin, and subsequently incubated until
60 min past 100% GVBD (M60). As seen in Fig. 5B, lanes 5
high molecular weight forms of CPEB in vivo. (A) Stage VI oocytes
ylated ubiquitin, 20 mM ubiquitin aldehyde, and 10% DMSO, or
0, and 60 min postinjection. Protein extracts were analyzed by
escence. Each lane contains two oocyte equivalents of protein. All
ntrol (lower panels). (B) The sample from Fig. 4A, lane 3, was
l protein samples. Fully grown Stage VI oocytes were induced to
), at GVBD50 (G50), and 60 min after 100% GVBD, i.e., completion
tin aldehyde were injected into oocytes at GVBD50. Samples were
iddle panel. Sizes of the heterogeneous CPEB forms are indicated
A-tagged CPEB is very heterogeneous at GVBD50 and when the
g of HA-CPEB mRNA overnight and induced to mature with
in MG132 injected oocytes (as described above). Samples were
dogenous CPEB (eCPEB) and HA-tagged CPEB (HA-CPEB) in theque,
meth
0, 3
umin
ng co
tiona
ion (E
biqui
e m
C) H
100 n
t M60
of enand 6, CPEB cross-reactive bands show the same size
s of reproduction in any form reserved.
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455PEST Domain and 26S Proteasome CPEB Degradationheterogeneity in samples taken immediately after injection
(lane 5), as in control-injected oocytes (lane 3). In oocytes
that complete GVBD, CPEB degradation is inhibited by
methylated ubiquitin and ubiquitin aldehyde: 70% is de-
graded in the presence of these inhibitors compared to 90%
degradation in control, buffer-injected oocytes (Fig. 5B,
compare lane 6 with lane 4). Additional experiments to
confirm that CPEB is ubiquitinated by immunoprecipita-
tion and immunoblotting with antiubiquitin antibodies
were unsuccessful (data not shown).
DISCUSSION
We are interested in how the fate of an individual CPEB
molecule is determined within the context of its transition
from translational repressor to translational activator. We
have begun to approach this by examining the principal
factors regulating the levels of CPEB during oogenesis and
oocyte maturation. In the current study, we have demon-
strated that CPEB is stockpiled during oogenesis and de-
graded by the proteasome pathway during oocyte matura-
tion. Deletion of a 14 amino acid PEST domain that is
highly conserved in vertebrates and clam completely stabi-
lizes CPEB, thus indicating that this domain is necessary
for targeting CPEB for degradation.
CPEB mRNA and protein amounts increase in parallel
until stage III of oogenesis, suggesting that existing CPEB
mRNA is directly translated into protein. Between stages V
and VI, CPEB mRNA levels decrease slightly and protein
levels increase slightly. CPEB mRNA levels may be adjust-
ing to an equilibrium between a low level of turnover and
the decrease in overall transcription that occurs late in
oogenesis (reviewed in Davidson, 1976), whereas the slight
increase in CPEB protein levels may be due to the overall
increase in protein synthetic rates that occurs during late
oogenesis (Taylor and Smith, 1985).
CPEB protein is synthesized primarily during oogenesis
and stockpiled in the oocyte. New CPEB synthesis during
oocyte maturation contributes 36 pg to the existing CPEB
pool during oocyte maturation. We have previously shown
that CPEB is an abundant protein present at 3 ng per stage
VI oocyte and 1 ng per mature oocyte or egg (Hake and
Richter, 1994). Thus, new CPEB accumulation during oo-
cyte maturation accounts for 3.6% of the CPEB pool present
in mature oocytes. This is clearly insufficient to account for
the 25% that persists after oocyte maturation. However,
since we do not know whether CPEB functions catalytically
or stoichiometrically, we cannot determine whether this is
a functionally significant contribution to the CPEB pool.
We believe it is unlikely that the slight increase in
translation of CPEB observed during oocyte maturation is
due to translational activation mediated by cytoplasmic
polyadenylation. To date, functional CPEs have been
mapped to within 100 nt 59 of the nuclear polyadenylation
hexanucleotide (Richter, 1999 and references therein).
Analysis of the CPEB mRNA 39UTR (Genbank No. e
Copyright © 2001 by Academic Press. All right14169) reveals a putative CPE; however, it is located 230
t 59 of the hexanucleotide. Additional analyses would be
equired to determine if this CPE is functional, and, given
he low level of CPEB translation during oocyte maturation,
ranslational activation of CPEB during this period does not
ppear to be a significant aspect of its regulation.
Protein degradation has a significant impact on the levels
f CPEB: 75% is degraded shortly after germinal vesicle
reakdown, the first visible sign that meiosis has been
einitiated (de Moor and Richter 1997; this study). We have
emonstrated that the decrease in CPEB protein concentra-
ion is not related to alterations in CPEB mRNA levels, as
hese remain stable throughout oocyte maturation. Indeed,
e find that CPEB degradation is dependent upon the
roteasome pathway.
In an effort to map the region within CPEB required for
egradation, we focused on a 28 amino acid PEST domain
hat is highly conserved in the vertebrate CPEB family (this
tudy) and contains a smaller domain that is also conserved
n clam p82/CPEB (Walker et al., 1999). PEST domains are
equired for the degradation of many different classes of
roteins by several different degradation pathways (Rech-
teiner and Rogers, 1996). There are several examples in
hich phosphorylation on specific serine and threonine
esidues within the PEST domain target the protein for the
biquitin-proteasome degradation pathway (Baeuerle, 1998;
leming and Wang, 2000; also see references in Rechsteiner
nd Rogers, 1996). Two lines of evidence suggest that this is
possible scenario for the involvement of the PEST domain
n CPEB degradation. First, the DPEST mutants of CPEB are
ot phosphorylated to the same extent as the wild-type
rotein (Fig. 4C). Only 50% of the DPEST deletion mutant
roteins shift in mobility during oocyte maturation, and, in
ddition, the size shift observed is not as great as it is for the
ild-type protein. Deletion of the PEST domain may re-
ove residues that are usually phosphorylated or a signal
ecessary for phosphorylation outside of the PEST domain.
he absence of these residues, and perhaps their nonphos-
horylated neighbors, may preclude recognition of CPEB by
3 ligases or other proteins that aid in targeting CPEB for
egradation by the proteasome. Further analysis of this
ossibility will require analysis of the metabolism of CPEB
ontaining point mutations of physiologically phosphory-
ated positions, in combination with an examination of the
roteins that may recognize this domain and mediate
argeting for degradation.
Second, we provide data suggesting that CPEB requires
biquitination for degradation. By using modified forms of
biquitin that perturb multiubiquitination and deubiquiti-
ation, we were able to stabilize a 74-kDa form of CPEB in
mmature oocytes that most likely contains one or two
biquitin conjugates (Fig. 5A, lane 3). Methylated ubiquitin
ypically leads to the accumulation of low molecular
eight protein–ubiquitin conjugates (Ben-Shahar et al.,
997; Pickart and Vella, 1988), whereas ubiquitin aldehyde
revents the breakdown of multiubiquitin conjugates (Dang
t al., 1998). The presence of these potential ubiquitin–
s of reproduction in any form reserved.
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456 Reverte, Ahearn, and HakeCPEB conjugates in immature oocytes suggests that the
ubiquitination machinery is functioning. This does not
result in the degradation of a significant fraction of CPEB in
immature oocytes, because treatment of immature oocytes
with inhibitors of the proteasome had no effect on the
accumulation of CPEB (data not shown).
The similarity of this immature oocyte form of CPEB
with the 74-kDa form observed at GVBD50 in the absence of
inhibitors leads us to speculate that the latter form may
represent CPEB that is mono- or diubiquitinated and in the
process of being targeted for degradation (Shaeffer, 1994).
These types of intermediates would be predicted to be very
transient. Indeed, although we have observed these modi-
fied forms of CPEB in oocytes from four different females at
GVBD50, we only see them when the oocytes are maturing
ynchronously and achieve 100% GVBD within 6 h.
Additional support for the requirement of ubiquitin in
argeting CPEB for degradation comes from our studies
emonstrating that injection of methylated ubiquitin and
biquitin aldehyde into maturing oocytes inhibits CPEB
egradation. Hershko et al. (1991) were similarly able to
elay cyclin degradation in clam oocyte extracts with
ethylated ubiquitin. They were unsuccessful, however, in
bserving the predicted monoubiquitinated species, pre-
umably due to the action of isopeptidases. The inclusion of
biquitin aldehyde in our experiments may have aided our
isualization of the higher molecular weight, potentially
biquitinated intermediates by inhibiting these isopepti-
ases.
It has recently been shown that the PEST domain of
PEB is necessary for microtubule binding (Groisman et al.,
000). In oocytes, CPEB is enriched in the animal pole,
resumably through its association with microtubules. In
leavage stage embryos, CPEB is associated with the mi-
otic apparatus and centrosome. This ensures that cyclin B1
rotein is concentrated near the mitotic apparatus, which
ppears to be a requirement for normal cell division (Gro-
sman et al., 2000). The tethering of CPEB to microtubules
ia the PEST domain may block accessibility of this domain
o other proteins that would modify and thus target it for
biquitination and proteasomal degradation. Protein inter-
ctions mediated via the PEST domain have been shown to
mpede target protein degradation in other systems: the
EST domains within IkBa and IkBb are bound by two
as-like guanine triphosphatases that interfere with recog-
ition of these domains by the degradative machinery
Fenwick et al., 2000). Although the domain required for
PEB degradation has been identified, and a compelling
uality in function of this domain has been elucidated, the
ature of the functional differences which allow one popu-
ation of CPEB to be targeted for degradation and yet
nother to be protected are still unknown.
In this study, we have shown that CPEB is stockpiled
uring oogenesis and degraded by the proteasome pathway
uring GVBD through recognition of the PEST domain.
egligible synthesis of CPEB occurs during oocyte matura-ion, suggesting that the segregation of CPEB into two
Copyright © 2001 by Academic Press. All rightools, one that is degraded, and one that is protected and
ersists for the promotion of polyadenylation, occurs
hrough the functional sequestration of CPEB. This could
e achieved perhaps by the interaction of CPEB, through its
EST domain, with various cellular components. Further
xperiments are in progress to examine this possibility.
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